G protein-coupled receptor-receptor tyrosine kinase receptor crosstalk:: Regulation of receptor sensitivity and roles of autocrine feedback loops and signal integration

被引:10
作者
Garcia-Sainz, J. Adolfo [1 ]
Romero-Avila, M. Teresa [1 ]
Molina-Munoz, Tzindilu [1 ]
Garcia-Pasquel, Maria-Jose [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico
关键词
G protein-coupled receptor; receptor tyrosine kinase; crosstalk; desensitization; EGF transactivation;
D O I
10.2174/157436208785699730
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Receptor tyrosine kinases (RTKs) can induce G protein-coupled receptor (GPCR) desensitization and phosphorylation. In some cases phosphorylation by RTKs on GPCRs tyrosine residues is involved, while in others indirect action through diverse protein kinases takes place. GPCRs stimulation can lead to RTK activation through the action of metalloproteinases, shedding of HB-EGF, and EGF receptor activation; such autocrine loop participates in the overall action triggered by GPCRs. Interestingly, it also has a role in GPCR phosphorylation and desensitization induced by activation of unrelated agents acting through their own GPCRs, and even in homologous desensitization. Phosphorylation and desensitization of some GPCRs by RTKs is pertussis toxin-sensitive, suggesting a role of G proteins. This might involve interaction between G proteins and RTKs but also of another autocrine loop, which includes sphingosine kinase I activation, sphingosine 1-phosphate generation and release and sphingosine 1-phosphate GPCR stimulation. RTKs can also use GPCRs as accessory signalling elements placing G proteins downstream of RTKs. In this signal integration mechanism, synthesis/release of GPCR agonists is not essential. Crosstalk between GPCRs and RTKs has both basic and clinical implications, and has roles in physiologic and pathologic conditions offering multiple sites for therapeutic intervention.
引用
收藏
页码:174 / 182
页数:9
相关论文
共 144 条
[1]   Structure and function of the type 1 insulin-like growth factor receptor [J].
Adams, TE ;
Epa, VC ;
Garrett, TPJ ;
Ward, CW .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (07) :1050-1093
[2]   Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells [J].
Akekawatchai, C ;
Holland, JD ;
Kochetkova, M ;
Wallace, JC ;
McColl, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) :39701-39708
[3]   Protein phosphatase-protein kinase interplay modulates α1b-adrenoceptor phosphorylation:: effects of okadaic acid [J].
Alcántara-Hernández, R ;
Vázquez-Prado, J ;
García-Sáinz, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (04) :724-730
[4]   Protein kinase Cα1b-adrenoceptor coimmunoprecipitation:: effect of hormones and phorbol myristate acetate [J].
Alcántara-Hernández, R ;
Leyva-Illades, D ;
García-Sáinz, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 419 (01) :9-13
[5]   Tethering of the platelet-derived growth factor ß receptor to G-protein-coupled receptors -: A novel platform for integrative signaling by these receptor classes in mammalian cells [J].
Alderton, F ;
Rakhit, S ;
Kong, KC ;
Palmer, T ;
Sambi, B ;
Pyne, S ;
Pyne, NJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :28578-28585
[6]   Rhodopsin phosphorylation: from terminating single photon responses to photoreceptor dark adaptation [J].
Arshavsky, VY .
TRENDS IN NEUROSCIENCES, 2002, 25 (03) :124-126
[7]   Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy [J].
Asakura, M ;
Kitakaze, M ;
Takashima, S ;
Liao, Y ;
Ishikura, F ;
Yoshinaka, T ;
Ohmoto, H ;
Node, K ;
Yoshino, K ;
Ishiguro, H ;
Asanuma, H ;
Sanada, S ;
Matsumura, Y ;
Takeda, H ;
Beppu, S ;
Tada, M ;
Hori, M ;
Higashiyama, S .
NATURE MEDICINE, 2002, 8 (01) :35-40
[8]   The beta-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase [J].
Baltensperger, K ;
Karoor, V ;
Paul, H ;
Ruoho, A ;
Czech, MP ;
Malbon, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1061-1064
[9]  
BANDAY AA, 2007, AM J PHYSL RENAL PHY
[10]   Gefitinib ('Iressa', ZD1839) and new epidermal growth factor receptor inhibitors [J].
Blackledge, G ;
Averbuch, S .
BRITISH JOURNAL OF CANCER, 2004, 90 (03) :566-572